Has James Fry received payments from drug or device companies?

Yes. Drug and device makers reported $2,508,549 in general payments to James Fry across 1,588 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean James Fry did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about James Fry come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

James Fry

Neurology with Special Qualifications in Child Neurology · Nashville, TNNPI 1659482305

Payments from drug & device makers

$2,508,549in general payments, 2019–2025

Across 1,588 payments — averaging $1579.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1.8M
Otsuka Pharmaceutical Development & Commercialization, Inc.$268K
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$216K
Biohaven Pharmaceutical Holding Company Ltd.$65K
Supernus Pharmaceuticals, Inc.$52K
Eli Lilly$43K
plus $61K from 40 others

$15,424in research payments, 2019–2025

Across 9 payments — averaging $1713.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Pfizer$14K
Eli Lilly$2K

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	450	$1,803,231
Otsuka Pharmaceutical Development & Commercialization, Inc.	5	$268,299
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	122	$216,292
Biohaven Pharmaceutical Holding Company Ltd.	23	$65,021
Supernus Pharmaceuticals, Inc.	295	$51,935
Eli Lilly	2	$42,913
Biohaven Pharmaceuticals, Inc.	10	$25,678
Ironshore Pharmaceuticals Inc.	92	$13,487
Pfizer	6	$7,246
SK Life Science, Inc.	139	$3,262
Neurocrine Biosciences, Inc.	40	$1,551
Neurelis, Inc.	51	$1,229
Aquestive Therapeutics, Inc.	63	$981
Tris Pharma Inc	46	$918
UCB, Inc.	23	$851
Jazz Pharmaceuticals Inc.	28	$835
Greenwich Biosciences, Inc.	18	$710
Eisai Inc.	37	$698
Corium, LLC	30	$660
Takeda Pharmaceuticals U.S.A., Inc.	21	$381
Catalyst Pharmaceuticals, Inc.	14	$302
Immedica Pharma US, Inc.	2	$269
Sunovion Pharmaceuticals Inc.	2	$244
Livanova USA, Inc.	6	$221
Pyros Pharmaceuticals, Inc.	7	$193
Neos Therapeutics, LP	9	$171
Mallinckrodt Enterprises LLC	2	$122
Otsuka America Pharmaceutical, Inc.	4	$108
Vertical Pharmaceuticals, LLC	6	$102
Amneal Pharmaceuticals LLC	4	$80
Collegium Pharmaceutical, Inc.	3	$63
Adlon Therapeutics L.p.	4	$63
Arbor Pharmaceuticals, Inc.	3	$57
Upsher-smith Laboratories LLC	3	$55
Zogenix Inc.	3	$53
Noven Therapeutics, LLC	2	$41
Sumitomo Pharma America, Inc.	2	$35
Avion Pharmaceuticals	2	$33
Natus Medical Incorporated	1	$30
Aucta Pharmaceuticals, Inc.	2	$28
Acadia Pharmaceuticals Inc	1	$27
Rhodes Pharmaceuticals L.p.	1	$20
Biomarin Pharmaceutical Inc.	1	$16
Novartis	1	$15
Shire North American Group Inc	1	$12
Aprecia Pharmaceuticals, LLC	1	$12

How this compares

$2,508,549 in reported general payments places this provider in the 95th percentile of 47 neurology with special qualifications in child neurology providers in Tennessee.

See all neurology with special qualifications in child neurology providers in Tennessee →

Other neurology with special qualifications in child neurology in Nashville

Jesus Pina GarzaNashville$1.4M
Jeffrey NeulNashville$885K
William BurnetteNashville$392K
Robert CarsonNashville$342K
Cary FuNashville$218K
Althea SheltonNashville$167K
Mariana CiobanuNashville$102K
Timothy LivingstonNashville$14K
Ngochanh VuNashville$4K
Kaitlin JamesNashville$2K

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →